company background image
EMBLA logo

Embla Medical hf CPSE:EMBLA Rapporto sulle azioni

Ultimo prezzo

DKK 29.60

Cap. di mercato

DKK 12.6b

7D

-4.5%

1Y

-3.4%

Aggiornato

21 Aug, 2024

Dati

Dati finanziari dell'azienda +

Embla Medical hf.

CPSE:EMBLA Rapporto sulle azioni

Cap. di mercato: DKK 12.6b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

EMBLA Panoramica delle azioni

Embla Medical hf., insieme alle sue controllate, fornisce prodotti ortopedici non invasivi in Europa, Medio Oriente, Africa, Americhe e Asia-Pacifico.

Informazioni sull'azienda

EMBLA analisi fondamentale
Punteggio fiocco di neve
Valutazione4/6
Crescita futura2/6
Prestazioni passate4/6
Salute finanziaria3/6
Dividendi0/6

Premi

Negoziato a 26% al di sotto della nostra stima del suo valore equo
Si prevede che gli utili cresceranno del 17.87% all'anno
Gli utili sono cresciuti del 35.3% nell'ultimo anno
Gli analisti concordano sul fatto che il prezzo delle azioni salirà di 21%

Analisi del rischio

Ha un alto livello di debito

Embla Medical hf. Concorrenti

Ambu

CPSE:AMBU B

DKK 40.7b

Demant

CPSE:DEMANT

DKK 60.0b

NuVasive

NasdaqGS:NUVA

US$2.1b

CONMED

NYSE:CNMD

US$2.1b

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Embla Medical hf
Prezzi storici delle azioni
Prezzo attuale dell'azioneDKK 29.60
Massimo di 52 settimaneDKK 35.70
Minimo di 52 settimaneDKK 25.25
Beta0.67
1Variazione di 1 mese1.02%
Variazione a 3 mesi3.86%
Variazione di 1 anno-3.43%
3Variazione a 3 anni-38.33%
Variazione a 5 anni-37.75%
Variazione dall'IPO438.18%

Notizie e aggiornamenti recenti

Earnings Beat: Embla Medical hf. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Jul 26
Earnings Beat: Embla Medical hf. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Calculating The Fair Value Of Embla Medical hf. (CPH:EMBLA)

Jul 17
Calculating The Fair Value Of Embla Medical hf. (CPH:EMBLA)

Market Participants Recognise Embla Medical hf.'s (CPH:EMBLA) Earnings

May 14
Market Participants Recognise Embla Medical hf.'s (CPH:EMBLA) Earnings

Embla Medical hf. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Apr 26
Embla Medical hf. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Recent updates

Earnings Beat: Embla Medical hf. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Jul 26
Earnings Beat: Embla Medical hf. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Calculating The Fair Value Of Embla Medical hf. (CPH:EMBLA)

Jul 17
Calculating The Fair Value Of Embla Medical hf. (CPH:EMBLA)

Market Participants Recognise Embla Medical hf.'s (CPH:EMBLA) Earnings

May 14
Market Participants Recognise Embla Medical hf.'s (CPH:EMBLA) Earnings

Embla Medical hf. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Apr 26
Embla Medical hf. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

A Look At The Fair Value Of Embla Medical hf. (CPH:OSSR)

Apr 10
A Look At The Fair Value Of Embla Medical hf. (CPH:OSSR)

Is Össur hf (CPH:OSSR) Using Too Much Debt?

Mar 23
Is Össur hf (CPH:OSSR) Using Too Much Debt?

Why Investors Shouldn't Be Surprised By Össur hf.'s (CPH:OSSR) P/E

Jan 21
Why Investors Shouldn't Be Surprised By Össur hf.'s (CPH:OSSR) P/E

Calculating The Intrinsic Value Of Össur hf. (CPH:OSSR)

Jan 03
Calculating The Intrinsic Value Of Össur hf. (CPH:OSSR)

Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

Nov 28
Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Nov 08
Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

A Look At The Fair Value Of Össur hf. (CPH:OSSR)

Sep 23
A Look At The Fair Value Of Össur hf. (CPH:OSSR)

We Think Össur hf (CPH:OSSR) Is Taking Some Risk With Its Debt

Aug 21
We Think Össur hf (CPH:OSSR) Is Taking Some Risk With Its Debt

Össur hf (CPH:OSSR) May Have Issues Allocating Its Capital

Jul 18
Össur hf (CPH:OSSR) May Have Issues Allocating Its Capital

Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 19% Below Its Share Price

Jun 14
Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 19% Below Its Share Price

Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

May 19
Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively

Mar 14
Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively

A Look At The Intrinsic Value Of Össur hf. (CPH:OSSR)

Jan 21
A Look At The Intrinsic Value Of Össur hf. (CPH:OSSR)

These 4 Measures Indicate That Össur hf (CPH:OSSR) Is Using Debt Reasonably Well

Dec 22
These 4 Measures Indicate That Össur hf (CPH:OSSR) Is Using Debt Reasonably Well

There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital

Dec 07
There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital

Are Investors Undervaluing Össur hf. (CPH:OSSR) By 37%?

Sep 21
Are Investors Undervaluing Össur hf. (CPH:OSSR) By 37%?

Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Sep 02
Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

Aug 16
Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 42% Above Its Share Price

Jun 16
Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 42% Above Its Share Price

Össur hf (CPH:OSSR) Will Want To Turn Around Its Return Trends

Jun 01
Össur hf (CPH:OSSR) Will Want To Turn Around Its Return Trends

Does Össur hf (CPH:OSSR) Have A Healthy Balance Sheet?

May 08
Does Össur hf (CPH:OSSR) Have A Healthy Balance Sheet?

Össur hf (CPH:OSSR) Will Be Hoping To Turn Its Returns On Capital Around

Feb 22
Össur hf (CPH:OSSR) Will Be Hoping To Turn Its Returns On Capital Around

Analysts Have Made A Financial Statement On Össur hf.'s (CPH:OSSR) Yearly Report

Feb 03
Analysts Have Made A Financial Statement On Össur hf.'s (CPH:OSSR) Yearly Report

Calculating The Fair Value Of Össur hf. (CPH:OSSR)

Nov 25
Calculating The Fair Value Of Össur hf. (CPH:OSSR)

Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Oct 17
Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Is Össur hf (CPH:OSSR) A Risky Investment?

Sep 28
Is Össur hf (CPH:OSSR) A Risky Investment?

Calculating The Fair Value Of Össur hf. (CPH:OSSR)

Aug 21
Calculating The Fair Value Of Össur hf. (CPH:OSSR)

Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively

Jul 11
Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively

Here's Why Össur hf (CPH:OSSR) Can Manage Its Debt Responsibly

May 28
Here's Why Össur hf (CPH:OSSR) Can Manage Its Debt Responsibly

Calculating The Fair Value Of Össur hf. (CPH:OSSR)

May 07
Calculating The Fair Value Of Össur hf. (CPH:OSSR)

There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital

Mar 25
There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital

We Think The Compensation For Össur hf.'s (CPH:OSSR) CEO Looks About Right

Mar 02
We Think The Compensation For Össur hf.'s (CPH:OSSR) CEO Looks About Right

We Think Össur hf (CPH:OSSR) Can Stay On Top Of Its Debt

Feb 22
We Think Össur hf (CPH:OSSR) Can Stay On Top Of Its Debt

Does The Market Have A Low Tolerance For Össur hf.'s (CPH:OSSR) Mixed Fundamentals?

Feb 09
Does The Market Have A Low Tolerance For Össur hf.'s (CPH:OSSR) Mixed Fundamentals?

What Kind Of Shareholders Own Össur hf. (CPH:OSSR)?

Jan 26
What Kind Of Shareholders Own Össur hf. (CPH:OSSR)?

Össur hf (CPH:OSSR) Shareholders Have Enjoyed An Impressive 115% Share Price Gain

Jan 08
Össur hf (CPH:OSSR) Shareholders Have Enjoyed An Impressive 115% Share Price Gain

We're Watching These Trends At Össur hf (CPH:OSSR)

Dec 21
We're Watching These Trends At Össur hf (CPH:OSSR)

Rendimenti per gli azionisti

EMBLADK Medical EquipmentDK Mercato
7D-4.5%0.7%-0.3%
1Y-3.4%11.3%25.4%

Ritorno vs Industria: EMBLA ha avuto una performance inferiore rispetto al Danish Medical Equipment che ha registrato un rendimento 11.3 % nell'ultimo anno.

Rendimento vs Mercato: EMBLA ha avuto una performance inferiore al mercato Danish che ha registrato un rendimento 25.4 % nell'ultimo anno.

Volatilità dei prezzi

Is EMBLA's price volatile compared to industry and market?
EMBLA volatility
EMBLA Average Weekly Movement4.8%
Medical Equipment Industry Average Movement5.7%
Market Average Movement4.3%
10% most volatile stocks in DK Market9.1%
10% least volatile stocks in DK Market2.8%

Prezzo delle azioni stabile: EMBLA non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 5% ) di EMBLA è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

FondatoI dipendentiAMMINISTRATORE DELEGATOSito web
19714,000Sveinn Solvasonwww.emblamedical.com

Embla Medical hf., insieme alle sue controllate, fornisce prodotti ortopedici non invasivi in Europa, Medio Oriente, Africa, Americhe e Asia-Pacifico. Opera attraverso tre segmenti: Protesi, Bracing & Supports e Patient Care. Il segmento Protesi offre prodotti meccanici, come protesi per arti inferiori e protesi per dita, e prodotti bionici controllati da microprocessore per piedi, ginocchia, mani, guaine, dita e altri componenti integrati.

Embla Medical hf. Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Embla Medical hf con la sua capitalizzazione di mercato?
EMBLA statistiche fondamentali
Capitalizzazione di mercatoDKK 12.64b
Guadagni(TTM)DKK 408.90m
Ricavi(TTM)DKK 5.49b

30.9x

Rapporto P/E

2.3x

Rapporto P/S

EMBLA è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
EMBLA Conto economico (TTM)
RicaviUS$819.70m
Costo del fatturatoUS$313.15m
Profitto lordoUS$506.55m
Altre speseUS$445.45m
GuadagniUS$61.10m

Ultimi guadagni dichiarati

Jun 30, 2024

Prossima data di guadagno

Oct 23, 2024

Utile per azione (EPS)0.14
Margine lordo61.80%
Margine di profitto netto7.45%
Rapporto debito/patrimonio netto54.3%

Come si è comportato EMBLA nel lungo periodo?

Vedi performance storica e confronto